NCT00182650
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
2,141 public trials
305 recruiting studies
Lymphoma trial results
NCT00195533
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +19 more
- Locations
-
- A Coruña, Spain
- Alcalá de Henares, Spain
- Alzira, Spain
- Barcelona, Spain
NCT00136474
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +9 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Completed
Clinical Study of Chemoradiation Followed by VIPD in Nasal Natural Killer (NK)/T-cell Lymphoma
NCT00418535
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
NCT00520637
- Conditions
- Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
- Locations
-
- Northwestern University, Feinberg School of Medicine, Division of Hematology/Oncology Chicago, Illinois, United States
- MD Anderson Cancer Center Houston, Texas, United States
NCT00006246
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +57 more
- Locations
-
- UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Duke Comprehensive Cancer Center Durham, North Carolina, United States
Completed
Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma
NCT00631579
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Hyperuricemia, +10 more
- Locations
-
- Sanofi-Aventis Tokyo, Japan
NCT00141648
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
- Liverpool Hospital Liverpool, New South Wales, Australia
- Calvary Mater Newcastle Newcastle, New South Wales, Australia
- Westmead Hospital Wentworthville, New South Wales, Australia
NCT00415103
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Hospital Universitario Gregorio Marañón Madrid, Spain
- Hospital Universitario La Paz Madrid, Spain
- Hospital Universitario la Princesa Madrid, Spain
- Hospital Clínico Universitario de Salamanca Salamanca, Spain
NCT00423410
- Conditions
- Advanced Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
- Locations
-
- Scottsdale Healthcare Scottsdale, Arizona, United States
- Tower Oncology Research Beverly Hills, California, United States
- Rebecca and John Moores UCSD Cancer Center San Diego, California, United States